PT Bhakti Multi Artha Tbk (ISX:BHAT) Research & Development: Rp0 Mil (TTM As of Sep. 2025)


ISX:BHAT PT Bhakti Multi Artha Tbk ISX:BHAT
70 GF Score
Price Rp1,770.00
GF Value Rp296.44
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is PT Bhakti Multi Artha Tbk Research & Development?

PT Bhakti Multi Artha Tbk ISX:BHAT 70 Research & Development is Rp0 Mil as of Sep. 2025. GuruFocus rates ISX:BHAT with a GF Score™ of 70/100 and a GF Value™ of Rp296.44 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Bhakti Multi Artha Tbk's Research & Development for the three months ended in Sep. 2025 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was Rp0 Mil.

PT Bhakti Multi Artha Tbk  (ISX:BHAT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Bhakti Multi Artha Tbk Research & Development Related Terms

PT Bhakti Multi Artha Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Bhakti Multi Artha Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bhakti Multi Artha Tbk Research & Development Chart

PT Bhakti Multi Artha Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

PT Bhakti Multi Artha Tbk Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:BHAT
70GF Score
PT Bhakti Multi Artha Tbk ISX:BHAT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bhakti Multi Artha Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Bhakti Multi Artha Tbk (ISX:BHAT) has a Research & Development of Rp0 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on PT Bhakti Multi Artha Tbk and its competitors.
Is PT Bhakti Multi Artha Tbk's Research & Development too high?
PT Bhakti Multi Artha Tbk's current Research & Development is Rp0 Mil. Overall, PT Bhakti Multi Artha Tbk has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Bhakti Multi Artha Tbk's Research & Development compare to AFL and MET?
PT Bhakti Multi Artha Tbk's Research & Development of Rp0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Bhakti Multi Artha Tbk and its competitors. PT Bhakti Multi Artha Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bhakti Multi Artha Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bhakti Multi Artha Tbk (ISX:BHAT) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp296.44, compared to a current price of Rp1,770.00 — trading 497.1% above its estimated fair value. The current Research & Development is Rp0 Mil. PT Bhakti Multi Artha Tbk's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Bhakti Multi Artha Tbk (ISX:BHAT), the current Research & Development is Rp0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bhakti Multi Artha Tbk (ISX:BHAT) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bhakti Multi Artha Tbk stock appears to be overvalued. The current stock price of Rp1,770.00 is trading 497.1% above its estimated GF Value™ of Rp296.44. GuruFocus considers PT Bhakti Multi Artha Tbk to be Significantly Overvalued.

Key valuation signals for ISX:BHAT:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp296.44 vs. price of Rp1,770.00 (497.1% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the ISX:BHAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Bhakti Multi Artha Tbk Business Description

Address Jalan Kuningan Barat 26, Kec. Mampang Prapatan, Selatan, Jakarta, IDN, 12710
PT Bhakti Multi Artha Tbk is an investment holding company. The Company's business sector is in the management consulting services field and holding companies. The company's segment includes Life insurance and Others. It generates maximum revenue from the Life insurance segment.
70GF Score

Get the complete analysis for ISX:BHAT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,770.00
Price
Rp296.44
GF Value